Cited by 94Liver physiology and pathologyCancer-related Molecular PathwaysDrug-Induced Hepatotoxicity and Protection

Early Increase in Cyclin-D1 Expression and Accelerated Entry of Mouse Hepatocytes into S Phase after Administration of the Mitogen 1,4-Bis[2-(3,5-Dichloropyridyloxy)] Benzene

Open access
Ledda-Columbano, Giovanna M., Pibiri, Monica, Loi, Roberto, Perra, Andrea, Shinozuka, Hisashi, Columbano, Amedeo·2000·The American Journal of Pathology

Abstract

We have previously demonstrated that hepatocyte proliferation induced by the mitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP) is independent of changes in cytokines, immediate early genes, and transcription factors that are considered to be necessary for regeneration of the liver after partial hepatectomy (PH) or necrosis. To further investigate the differences between mitogen-induced mouse hepatocyte proliferation and liver regeneration after PH, we have measured the expression of cyclin D1, cyclin D3, cyclin E, and cyclin A and of the cyclin-dependent kinases CDK2, CDK4, and CDK6. The involvement of the cyclin-dependent kinase inhibitors p21 and p27 and of the oncosuppressor gene p53 was also examined at different times after stimulation of hepatocyte proliferation. Results showed that a single administration of TCPOBOP caused a very rapid increase in the levels of cyclin D1, a G1 protein, when compared with two thirds PH (8 hours versus 30 hours). The early increase in cyclin D1 protein levels was associated with a faster onset of increased expression of S-phase-associated cyclin A (24 hours versus 36 hours with PH mice). Accordingly, measurement of bromodeoxyuridine (BrdU) incorporation revealed that, although approximately 8% of hepatocytes were BrdU-positive as early as 24 hours after TCPOBOP, no significant changes in BrdU incorporation were observed at the same time point after two thirds PH. The expression of other proteins involved in cell cycle control, such as cyclin-dependent kinases (CDK4, CDK2, CDK6), was also analyzed. Results showed that expression of CDK2 was induced much more rapidly in TCPOBOP-treated mice (2 hours) than in mice subjected to PH (36 hours). A different pattern of expression in the two models of hepatocyte proliferation, although less dramatic, was also observed for CDK4 and CDK6. Expression of the CDK inhibitors p21 and p27 and the oncosuppressor gene p53 variably increased after two thirds PH, whereas basically no change in protein levels was found in TCPOBOP-treated mice. The results demonstrate that profound differences in many cell cycle-regulatory proteins exist between direct hyperplasia and compensatory regeneration. Cyclin D1 induction is one of the earlier events in hepatocyte proliferation induced by the primary mitogen TCPOBOP and suggests that a direct effect of the mitogen on this cyclin may be responsible for the rapid onset of DNA synthesis observed in TCPOBOP-induced hyperplasia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0002-9440(10)64709-8

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CAR's pro-proliferative role in liver is mediated through induction of c-Myc, Foxm1, and cyclin D1, and modulation of β-catenin and YAP signaling pathways.

    “Prior studies have focused primarily on the pro-proliferative role of CAR in the liver, mediated through the induction of factors such as cellular-myelocytomatosis oncogene (c-Myc),15 forkhead box m1 (Foxm1),15 and cyclin D1 (Ccnd1),16 as well as modulation of β-catenin17,18 and Yes-associated protein19, 20, 21, 22 signaling pathways.”

    From Constitutive Androstane Receptor Regulates Bile Acid Homeostasis and Metabolism During Liver Regeneration (2026) · cites this paper as [16]

    Citation 16 is attached to the cyclin D1 portion of the sentence, not the separately cited factors and pathways. The Discussion (page unavailable) reports rapid induction of cyclin D1 in mouse liver after treatment with TCPOBOP, which the paper says activates CAR. It proposes, but does not establish, that the activated receptor induces cyclin D1; the claim states that mechanism more firmly than the source does. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 54 · Cited by 94

Research works printed but not linked: 49

  1. Fausto N, Laird AD, Webber EM: Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995, 9:1527-1536
  2. Taub R: Transcriptional control of liver regeneration. FASEB J 1996, 10:413-427
  3. Michalopoulos GK, DeFrances MC: Liver regeneration. Science 1997, 276:60 -66
  4. Morgan DO: Cyclin dependent kinase: engines, clocks, and micro- processors. Annu Rev Cell Dev Biol 1997, 13:261-291
  5. Grana X, Reddy PE: Cell cycle control in mammalian cells: role of cyclins, cyclin-dependent kinases (CDKs), growth suppressor genes and cyclin dependent kinase inhibitors (CKIs). Oncogene 1995, 11: 211-219
  6. Pines J: Cyclins and cyclin dependent kinases: a biochemical view. Biochem J 1995, 308:697-711
  7. Sherr CJ: Cancer cell cycles. Science 1996, 274:1672-1677
  8. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995, 9:1149 -1163
  9. Nakanishi M, Adami GR, Robetoye RS, Noda A, Venable SF, Dimitrov D, Pereira-Smith OM, Smith JR: Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA. Proc Natl Acad Sci USA 1995, 92:4352-4356
  10. MacLeod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T: p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995, 9:935-944
  11. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expres- sion screen. Exp Cell Res 1994, 211:90 -98
  12. Guo K, Wang J, Andres V, Smith RC, Walsh K: MyoD-induced ex- pression of p21 inhibits cyclin-dependent kinase activity upon myo- cyte terminal differentiation: Mol Cell Biol 1995, 15:3823-3829
  13. Marx J: Cell biology: cell cycle inhibitors may help brake growth as cells develop. Science 1995, 267:963-964
  14. Shim J, Lee H, Park J, Kim H, Choi EJ: A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 1996, 381:804 - 806
  15. Zhang H, Hannon GJ, Beach D: p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 1994, 8:1750 -1758
  16. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E: New functional activities for the p21 family of CDK inhibitors. Genes Dev 1997, 11:847-862
  17. Albrecht JH, Poon RY, Ahonen CL, Rieland BM, Deng C, Crary GS: Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver. Oncogene 1998, 16: 2141-2150
  18. Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ: CCAAT/enhancer-binding protein ␣ (C/EBP␣) inhibits cell prolifera- tion through the p21 (WAF-1/Cip-1/SDI-1) protein. Genes Dev 1996, 10:804 -815
  19. Columbano A, Ledda-Columbano GM, Pibiri M, Piga R, Shinozuka H, DeLuca V, Cerignoli F, Tripodi M: Increased expression of c-fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP. Oncogene 1997, 14:857-863
  20. Ledda-Columbano GM, Curto M, Piga R, Zedda AI, Menegazzi M, Sartori C, Shinozuka H, Bluethmann H, Poli V, Ciliberto G, Columbano A: In vivo hepatocyte proliferation is inducible through a TNF, and IL-6-independent pathway. Oncogene 1998, 17:1039 -1044
  21. Menegazzi M, Carcereri A, Suzuki H, Shinozuka H, Pibiri M, Piga R, Columbano A, Ledda-Columbano GM: Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with in- creases in activation of transcription factors NF-kB and AP-1 or expression of tumor necrosis factor-␣. Hepatology 1997, 25:585-592
  22. Ohmura T, Ledda-Columbano GM, Piga R, Columbano A, Glemba J, Katyal SL, Locker J, Shinozuka H: Hepatocyte proliferation induced by a single dose of a peroxisome proliferator. Am J Pathol 1996, 148:815-824
  23. Columbano A, Shinozuka H: Liver regeneration versus direct hyper- plasia. FASEB J 1996, 10:1118 -1128
  24. Honkakoski P, Zelko I, Sueyohi T, Negishi M: The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the pheno- barbital-responsive enhancer module of the CIP2B gene. Mol Cell Biol 1998, 18:5652-5658
  25. Peters JM, Cattley RC, Gonzalez FJ: Role of PPAR ␣ in the mecha- nism of action of the nongenotoxic carcinogen and peroxisome pro- liferator Wy-14,643. Carcinogenesis 1997, 18:2029 -2033
  26. Bucher NLR: Regeneration of mammalian liver. Int Rev Cytol 1963, 15:245-300
  27. Hoffman AL, Rosen HR, Ljubimova JU, Sher L, Podesta LG, Dem- etriou AA, Makowka L: Hepatic regeneration: current concepts and clinical implications. Semin Liver Dis 1994, 14:190 -210
  28. Brodsky WY, Uryvaeva IV: Cell polyploidy: its relation to tissue growth and function. Int Rev Cytol 1973, 50:275-332
  29. Paulsen JE: Variations in regenerative growth of mouse liver following partial hepatectomy. In Vivo 1990, 4:235-238
  30. Lorup C: An autoradiographic study of the 3 H-uridine and 3 H-thymi- dine incorporation in the regenerating mouse liver. Cell Tissue Kinet 1977, 10:477-485
  31. Morello D, Fitzgerald MJ, Babinet C, Fausto N: C-myc, c-fos, and c-jun regulation in the regenerating livers of normal, and H-2K/c c-myc transgenic mice. Mol Cell Biol 1990, 10:3185-3193
  32. Goyette M, Petropulos GJ, Shank PR, Fausto N: Expression of cellular oncogene during liver regeneration. Science 1983, 219:510 -512
  33. Makino R, Hayashi K, Sugiomura TC: C-myc transcript is induced in rat liver at a very early stage of regeneration or by cycloheximide treatment. Nature 1984, 319:694 -698
  34. Coni P, Simbula G, Carcereri DePrati A, Menegazzi M, Suzuki H, Sarma DSR, Ledda-Columbano GM, Columbano A: Differences in the steady-state levels of c-fos, c-jun and c myc-messenger RNA during mitogen-induced liver growth and compensatory regeneration. Hepa- tology 1993, 17:1109 -1116
  35. Goldsworthy TL, Goldsworthy SM, Sprankle CS, Butterworth BE: Ex- pression of myc, fos and H-ras associated with chemically induced cell proliferation in the rat liver. Cell Prolif 1994, 27:269 -278
  36. Skrtic S, Ekberg S, Wallenius V, Enerbak S, Hedin L, Jansson JO: Changes in expression of CCAT/enhancer binding protein a (C/EBPa) and C/EBP␤ in rat liver after partial hepatectomy but not after treat- ment with cyproterone acetate. J Hepatol 1997, 27:903-911
  37. Altucci L, Addeo R, Cicatiello L, Dauvois S, Parker MG, Beato M, Truss M, Sica V, Bresciani F, Weisz A: 17b-estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic simulation of G1-arrested human breast cancer cells. Oncogene 1996, 12:2315-2324
  38. Altucci L, Addeo R, Cicatiello L, Germano D, Pacilio C, Battista T, Cancemi M, Petrizzi VB, Bresciani F, Weitz A: Estrogen induces early and timed activation of cyclin-dependent kinases 4, 5 and 6 and increases cyclin mRNA expression in rat uterus. Endocrinology 1997, 138:978 -984
  39. Neuman E, Ladha MH, Lin N, Upton TM, Miller SJ, DiRenzo J, Pestell RG, Hinds PW, Dowdy SF, Brown M, Ewen ME: Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4: Mol Cell Biol 1997, 17:5338 -5347
  40. Planas-Silva MD, Weinberg RA: Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol Cell Biol 1997, 17:4059 - 4069
  41. Geum D, Sun W, Paik SK, Lee CC, Kim K: Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3. Mol Reprod Dev 1997, 46:450 -458
  42. Motokura T, Keyomarsi K, Kronenberg HM, Arnold A: Cloning and characterization of human cyclin D3, a cDNA closely related in se- quence to the PRAD1/cyclin D1 proto-oncogene. J Biol Chem 1992, 267:20412-20415
  43. Matsushima H, Roussel MF, Ashum RA, Sherr CJ: Colony-stimulation factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1995, 65:701-713
  44. Sun W, Lee DK, Lee CC, Kim K: Differential expression of D-type G1 cyclins during mouse development and liver regeneration in vivo. Mol Reproduct Dev 1996, 43:414 -420
  45. Albrecht JH, Meyer AH, Hu MY: Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration. Hepatology 1997, 25:557-563
  46. Diwan BA, Lubet RA, Ward JM, Hrabie JA, Rice JM: Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy- )]benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepato- cellular tumors in F344/NCr rats initiated with N-nitrosodiethylamine. Carcinogenesis 1992, 13:1893-1901
  47. Reddy JK, Lalwani ND: Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and indus- trial plasticizers to humans. Crit Rev Toxicol 1983, 12:1-58
  48. Kraupp-Grasl B, Huber W, Putz B, Gerbracht U, Schulte-Hermann R: Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver. Cancer Res 1990, 50: 3701-3708
  49. Marsman DS, Popp JA: Biological potential of basophilic hepatocel- lular foci and hepatic adenoma induced by the peroxisome prolifera- tor WY 14,643. Carcinogenesis 1994, 15:111-117

Authors
Ledda-Columbano, G. M., Pibiri, M., Loi, R., Perra, A., Shinozuka, H., & Columbano, A.
Affiliations
  • University of Cagliari (IT)
  • University of Pittsburgh (US)
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2000-01
Volume
156
Issue
1
Pages
91-97
ISSN
0002-9440 (ISSN-L)
OpenAlex
W2004904102
Cited by
94
References
54
Citations by year
2026: 1 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 4 · 2017: 6 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 5 · 2012: 1
FWCI
3.27
Type
journal article
Language
en
Open access
Locations
  • American Journal Of Pathology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
hepatocyte proliferation, TCPOBOP, partial hepatectomy, liver regeneration, cell cycle regulation, cyclin-dependent kinases, CDK2, cyclin A, cyclin D3, cyclin E, p21, p27, p53, compensatory regeneration, S phase entry, bromodeoxyuridine
MeSH terms
Animals, Bromodeoxyuridine, Female, Hepatectomy, Liver, Mice, Inbred Strains, Microtubule-Associated Proteins, Mitogens, Pyridines, Time Factors, Gene Expression, Genes, p53, S Phase, Cyclins, Cell Cycle Proteins, Cyclin A, Cyclin D1, Tumor Suppressor Proteins, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase Inhibitor p27, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review